This small molecule inhibitor targets the light chain of botulinum neurotoxin type A (BoNT/A), effectively blocking its proteolytic activity with an IC50 of 4.9 µM. It is a valuable research tool for studying BoNT/A mechanism and for in vitro assays aimed at developing therapeutic interventions against botulism.